The relationship between IL-6 and type2 biomarkers has been investigated by Li et al.37, and the authors report that a combination of IL-6 level (representing non-type 2 asthma) and FeNO value or blood eosinophil count (representing type 2 asthma) might identify different asthma endotypes. The gene discussed is IL6; the disease is asthma.